Tehranifar Parisa, Protacio Angeline, Schmitt Karen M, Desperito Elise, Oskar Sabine, Potter Alan J, Engmann Natalie J, Terry Mary Beth
Department of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St, New York, NY, 10032, USA.
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
Cancer Causes Control. 2015 Oct;26(10):1393-403. doi: 10.1007/s10552-015-0630-4. Epub 2015 Jul 14.
The metabolic syndrome [MetS, clustering of elevated blood pressure, triglycerides and glucose, reduced high-density lipoprotein cholesterol (HDL-C), abdominal obesity] has been associated with increased breast cancer risk, but less is known about its association with mammographic breast density, a strong risk factor for breast cancer.
We collected data on risk factors, body size, and blood pressure via in-person interviews and examinations and measured glucose, triglycerides, and HDL-C from dried blood spots from women recruited through a mammography screening clinic (n = 373; 68 % Hispanic, 17 % African-American, 63 % foreign born). We performed linear regression models to examine the associations of each MetS component and the MetS cluster (≥3 components) with percent density and dense breast area, measured using a computer-assisted technique and Cumulus software.
About 45 % of women had the MetS, with the prevalence of the individual components ranging from 68 % for abdominal obesity to 33 % for elevated triglycerides. The prevalence of the MetS increased with higher body mass index (BMI) and postmenopausal status, but did not vary substantially by ethnicity, immigrant generational status, parity, age at menarche, or alcohol consumption. Low HDL-C (<50 mg/dL), but not the MetS cluster or the other MetS components, was associated with larger dense breast area after adjusting for age, BMI, fasting time, and educational attainment (β = 8.77, 95 % CI 2.39, 15.14). The MetS and its individual components were not associated with BMI-adjusted percent density.
HDL-C alone may have an influence on dense breast tissue that is independent of BMI, and may be in the same direction as its association with breast cancer risk.
代谢综合征[MetS,包括高血压、甘油三酯和血糖升高、高密度脂蛋白胆固醇(HDL-C)降低以及腹部肥胖的聚集]与乳腺癌风险增加有关,但关于其与乳腺钼靶密度(一种强大的乳腺癌风险因素)的关联知之甚少。
我们通过面对面访谈和检查收集了风险因素、体型和血压数据,并从通过乳腺钼靶筛查诊所招募的女性的干血斑中测量了葡萄糖、甘油三酯和HDL-C(n = 373;68%为西班牙裔,17%为非裔美国人,63%出生于国外)。我们进行了线性回归模型,以研究每个MetS组分和MetS聚类(≥3个组分)与使用计算机辅助技术和积云软件测量的密度百分比和致密乳腺面积之间的关联。
约45%的女性患有MetS,各组分的患病率从腹部肥胖的68%到甘油三酯升高的33%不等。MetS的患病率随着体重指数(BMI)升高和绝经后状态而增加,但在种族、移民代际状态、产次、初潮年龄或饮酒方面没有显著差异。调整年龄、BMI、禁食时间和教育程度后,低HDL-C(<50 mg/dL)而非MetS聚类或其他MetS组分与更大的致密乳腺面积相关(β = 8.77,95%CI 2.39,15.14)。MetS及其各个组分与BMI调整后的密度百分比无关。
单独的HDL-C可能对致密乳腺组织有独立于BMI的影响,并且可能与其与乳腺癌风险的关联方向相同。